Duke logo

ECOG-ACRIN EAY131 (Solid Tumors, Lymphoma, Multiple Myeloma) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to see if different study drugs or drug combinations that target specific genetic changes found in some cancers will shrink the tumor and/or prolong the time to progression.

What is the Condition Being Studied?

Solid Tumors, Lymphoma, Multiple Myeloma

Who Can Participate in the Study?

Adults with solid tumors, lymphoma, or multiple myeloma who:
- Have progressed following at least one line of standard systemic therapy and for whose disease no standard treatment exists that has been shown to prolong survival
- Are not pregnant or nursing

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Have a sample of your tumor tissue tested to see if it contains a genetic change that is targeted by one or more of the drugs being tested as part of this study

Study Details

Full Title
ECOG-ACRIN EAY131: Molecular Analysis for Therapy Choice (MATCH)
Principal Investigator
Medical Oncologist
Protocol Number
IRB:PRO00065775
NCT:NCT02465060
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
studyrecruitment@duke.edu
or
919-681-5698